Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News ACC 2016

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

Shelley Wood

April 12, 2016

News Conference News ACC 2016

CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men

Caitlin E. Cox

April 08, 2016

News Conference News ACC 2016

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Shelley Wood

April 07, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Conference News ACC 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Michael O'Riordan

April 06, 2016

News Conference News ACC 2016

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

Todd Neale

April 05, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Conference News ACC 2016

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

L.A. McKeown

April 03, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2015

Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension

Todd Neale

March 17, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

Presentation ACC 2015

Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients

Presenter: Susheel K. Kodali

March 15, 2015

News Conference News ACC 2015

Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD

L.A. McKeown

March 14, 2015

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Conference News ACC 2014

TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease

Jason Kahn

March 30, 2014

News Conference News ACC 2013

Coronary CTA Predictive, Resource-Saving When Used in Emergency Department

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

Presentation ACC 2012

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Presenter: Susheel K. Kodali

March 26, 2012

Advertisement

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients

Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease

Coronary CTA Predictive, Resource-Saving When Used in Emergency Department

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Study Looks at Long-term Mortality Predictors in TAVR Patients

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content